குடும்ப உயர் ஆபத்து மதிப்பீடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குடும்ப உயர் ஆபத்து மதிப்பீடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குடும்ப உயர் ஆபத்து மதிப்பீடு Today - Breaking & Trending Today

DGAP-News: Molecular Health GmbH: Molecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel


DGAP-News: Molecular Health GmbH: Molecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel
PMS2, respectively. Therefore, testing
BRCA1/2 genes and other heritable cancer-associated genes is becoming increasingly important: both to evaluate the affected patient s individual risk of developing cancer
[1],[2], and as a predictive biomarker and companion diagnostic test for certain drugs
[3]. Whereas MH Guide/BRCA detects variants in HBOC-associated genes, MH Guide/Mendel can analyze large gene panels as well as whole-exome or whole-genome data, so that many different hereditary diseases can be identified at once.
With this collaboration in place, Japanese patients will benefit from state-of-the-art genetic identification of inherited diseases like Hereditary Breast and Ovarian Cancer and many other diseases. This will allow sooner diagnosis and potentially earlier therapeutic intervention , said ....

Baden Wuberg , Eva Bauer , Kostenloser Wertpapierhandel , Christian Meisel , Katja Arnold , Laurie Doyle , Thomas Koenig , Molecular Health Gmb , Molecular Health Gmbh Key , Mc Services , Molecular Health , National Comprehensive Cancer Network , Distribution Services , Molecular Health Gmbh , Health Gmbh , Ovarian Cancer , Hereditary Breast , Chief Medical Officer , Tohoku Medical , Familial High Risk Assessment , Rev Clin Oncol , Corporate News , Regulatory Announcements , ஈவா பாயர் , கிறிஸ்துவர் மீசெல் , காடிய அர்னால்ட் ,

ESOU 2021: ESUR Lecture: Genetic Testing for Prostate Cancer: When and How?


ESOU 2021: ESUR Lecture: Genetic Testing for Prostate Cancer: When and How?
(UroToday.com) At the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting, the EAU Section of Urological Research (ESUR) lecture was provided by Dr. Karen Knudsen discussing when and how to provide genetic testing for prostate cancer. Dr. Knudsen pointed out that there is an extraordinary burden of prostate cancer in the US, ranked as #1 for males in estimated new cases and #2 in estimated cancer-related deaths. Germline testing is revolutionizing care, with 12-17% of metastatic patients having germline mutations and 5-7% of early-stage patients having germline mutations. As such, germline testing is impacting precision medicine and tailored screening approaches, which also has an impact on families for hereditary cancer risk. ....

United States , Veda Giri , Zachary Klaassen , Karen Knudsen , European Association Of Urology , Sidney Kimmel Cancer Center , Jefferson Health System , Augusta University Medical College Of Georgia , Jefferson Health Enterprise , Georgia Cancer Center , Grade Group , Section Of Urological Research , Oncology Services , National Comprehensive Cancer Network , Oncological Urology , Virtual Annual Meeting , Neurological Research , Philadelphia Consensus Conference , Genetic Testing , Inherited Prostate Cancer Risk , Philadelphia Prostate Cancer Consensus Conference , Germline Testing , Prostate Cancer , Familial High Risk Assessment , Prostate Cancer Version , Executive Vice President ,